<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-132869" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Anesthesia for Transplant Surgery</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Diwan</surname>
            <given-names>Dhruti</given-names>
          </name>
          <aff>Medical College of Georgia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Paramvir</given-names>
          </name>
          <aff>Augusta University Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dhruti Diwan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Paramvir Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-132869.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>With the increasing number of organ procurement and transplantation, it is essential to know the needs of this patient population's pathophysiology and administer anesthesia to improve graft survival and functioning. This activity will focus on anesthesia for kidney, pancreas, and liver transplant surgery&#x02014;the role of the interprofessional team in the evaluation and management of the recipient and donor.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the indications and contraindications of kidney, pancreas, and liver transplants.</p></list-item><list-item><p>Outline the anesthesia monitoring devices used during kidney, pancreas, and liver transplant surgeries.</p></list-item><list-item><p>Ex[plain pre-transplant screening and optimization in kidney, pancreas, and liver transplant surgery.</p></list-item><list-item><p>Summarize anesthesia, intraoperative complication, and management in kidney, pancreas, and liver transplantation by an interprofessional team.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=132869&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=132869">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-132869.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>As per the Organ Procurement and Transplantation Network registry, the total number of people on the waitlist is 107,485 (as of 5/19/2021). United Network for Organ Sharing is a non-profit organization with local organ procurement organizations to match the donor with the recipient. Hence, it becomes essential to register a patient early, evaluate, and&#x000a0;optimize&#x000a0;them. So, whenever an appropriately matched organ is available, the patient can be scheduled for surgery.</p>
      </sec>
      <sec id="article-132869.s3" sec-type="Indications">
        <title>Indications</title>
        <p>The main indication of an organ transplant is an irreversible failure. The reason for organ failure can be an organ disease or secondary to systemic disease. Various bridge therapy is used till the organ transplantation is achieved to maintain that organ function.</p>
        <p>
<bold>Kidney Transplant</bold>
</p>
        <p>In kidney transplantation, a person becomes a candidate for organ recipient when there is an irreversible decrease in glomerular filtration rate of less than 20 ml/min/1.73 m<sup>2</sup>.<xref ref-type="bibr" rid="article-132869.r1">[1]</xref>&#x000a0;See <bold>Table. </bold>Causes of Kidney Failure.</p>
        <table-wrap id="article-132869.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. Causes of Kidney Failure</title>
          </caption>
          <table style="width: 1064.2px;">
            <tbody>
              <tr>
                <td style="width: 212px;" rowspan="1" colspan="1">&#x000a0;Kidney</td>
                <td style="width: 212px;" rowspan="1" colspan="1">
<p>Glomerular disease</p>
</td>
                <td style="width: 835.198px;" rowspan="1" colspan="1">
<p>Glomerulonephritis, glomerulosclerosis, immunoglobulin A nephropathy, hemolytic uremic syndrome, membranous nephropathy</p>
</td>
              </tr>
              <tr>
                <td style="width: 212px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 212px;" rowspan="1" colspan="1">
<p>Polycystic disease</p>
</td>
                <td style="width: 835.198px;" rowspan="1" colspan="1">
<p>Adult and pediatric polycystic disease</p>
</td>
              </tr>
              <tr>
                <td style="width: 212px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 212px;" rowspan="1" colspan="1">
<p>Renal vascular disease</p>
</td>
                <td style="width: 835.198px;" rowspan="1" colspan="1">
<p>Polyarteritis, renal artery thrombosis, malignant hypertension</p>
</td>
              </tr>
              <tr>
                <td style="width: 212px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 212px;" rowspan="1" colspan="1">
<p>Tubulointerstitial disease</p>
</td>
                <td style="width: 835.198px;" rowspan="1" colspan="1">
<p>Analgesic nephropathy, chemotherapy-induced nephritis, gout, radiation nephritis, obstructive uropathy, urolithiasis, and nephrolithiasis</p>
</td>
              </tr>
              <tr>
                <td style="width: 212px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 212px;" rowspan="1" colspan="1">
<p>Congenital disease</p>
</td>
                <td style="width: 835.198px;" rowspan="1" colspan="1">
<p>Hypoplasia, aplasia, dysplasia, obstructive uropathy, cystinosis</p>
</td>
              </tr>
              <tr>
                <td style="width: 212px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 212px;" rowspan="1" colspan="1">
<p>Neoplasms</p>
</td>
                <td style="width: 835.198px;" rowspan="1" colspan="1">
<p>Renal cell carcinoma, Wilms tumor, Lymphoma, Myeloma</p>
</td>
              </tr>
              <tr>
                <td style="width: 212px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 212px;" rowspan="1" colspan="1">
<p>Graft failure</p>
</td>
                <td style="width: 835.198px;" rowspan="1" colspan="1">
<p>&#x000a0;Acute, subacute, and chronic</p>
</td>
              </tr>
              <tr>
                <td style="width: 212px;" rowspan="1" colspan="1">Systemic</td>
                <td style="width: 212px;" rowspan="1" colspan="1">
<p>Diabetes</p>
</td>
                <td style="width: 835.198px;" rowspan="1" colspan="1">
<p>Uncontrolled juvenile or adult diabetes</p>
</td>
              </tr>
              <tr>
                <td style="width: 212px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 212px;" rowspan="1" colspan="1">
<p>Hypertension</p>
</td>
                <td style="width: 835.198px;" rowspan="1" colspan="1">
<p>Hypertensive nephrosclerosis</p>
</td>
              </tr>
              <tr>
                <td style="width: 212px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 212px;" rowspan="1" colspan="1">
<p>Inflammatory disease</p>
</td>
                <td style="width: 835.198px;" rowspan="1" colspan="1">
<p>Rheumatoid arthritis, amyloidosis, sarcoidosis, Wegner&#x02019;s granulomatosis, systemic lupus erythematosus, Goodpasture&#x02019;s syndrome</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Living donor kidney transplant: In the case of a living donor transplant, the recipient can be in the&#x000a0;early stages&#x000a0;of ESRD and not started on dialysis. Living donor kidney transplants have shown better graft survival and function.&#x000a0;&#x000a0;</p>
        <p>
<bold>Pancreas Transplant&#x000a0;&#x000a0;&#x000a0;</bold>
</p>
        <p>The causes of pancreatic failure are diabetes mellitus type I and II, chronic pancreatitis, pancreatic cancer, biliary duct cancer, and graft failure. It can be performed alone, simultaneous pancreatic and kidney transplantation, or pancreas after kidney transplantation.&#x000a0;&#x000a0;&#x000a0;&#x000a0;</p>
        <p><bold>Liver Transplant</bold>&#x000a0;&#x000a0;</p>
        <p>The <bold>Table. </bold>Various Causes of Liver Failure below outlines some causes of liver failure.</p>
        <table-wrap id="article-132869.table1" position="float" orientation="portrait">
          <caption>
            <title>Table. Various Causes of Liver Failure</title>
          </caption>
          <table style="width: 1057px;">
            <tbody>
              <tr>
                <td style="width: 114px;" rowspan="1" colspan="1">
<p>Liver</p>
</td>
                <td style="width: 113px;" rowspan="1" colspan="1">
<p>Cirrhosis</p>
</td>
                <td style="width: 138px;" rowspan="1" colspan="1">
<p>Non-cholestasis</p>
</td>
                <td style="width: 664px;" rowspan="1" colspan="1">
<p>Alcoholic, post necrotic (type A, B, C, D) cryptogenic</p>
</td>
              </tr>
              <tr>
                <td style="width: 114px;" rowspan="1" colspan="1">
</td>
                <td style="width: 113px;" rowspan="1" colspan="1">
</td>
                <td style="width: 138px;" rowspan="1" colspan="1">
<p>Cholestasis</p>
</td>
                <td style="width: 664px;" rowspan="1" colspan="1">
<p>Primary biliary cirrhosis, primary sclerosing cholangitis, biliary atresia</p>
</td>
              </tr>
              <tr>
                <td style="width: 114px;" rowspan="1" colspan="1">
</td>
                <td style="width: 113px;" rowspan="1" colspan="1">
<p>Acute hepatic necrosis</p>
</td>
                <td style="width: 138px;" rowspan="1" colspan="1">
</td>
                <td style="width: 664px;" rowspan="1" colspan="1">
<p>Acute or chronic Hepatitis B and hepatitis C, drug-induced (acetaminophen, aspirin, herbal supplements), toxins, wild mushroom poisoning</p>
</td>
              </tr>
              <tr>
                <td style="width: 114px;" rowspan="1" colspan="1">
</td>
                <td style="width: 113px;" rowspan="1" colspan="1">
<p>Malignant</p>
</td>
                <td style="width: 138px;" rowspan="1" colspan="1">
</td>
                <td style="width: 664px;" rowspan="1" colspan="1">
<p>Hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma</p>
</td>
              </tr>
              <tr>
                <td style="width: 114px;" rowspan="1" colspan="1">
<p>Systemic</p>
</td>
                <td style="width: 113px;" rowspan="1" colspan="1">
<p>Metabolic</p>
</td>
                <td style="width: 138px;" rowspan="1" colspan="1">
</td>
                <td style="width: 664px;" rowspan="1" colspan="1">
<p>Wilson&#x02019;s disease, hemochromatosis, tyrosinemia, hemosiderosis, alpha 1 antitrypsin deficiency</p>
</td>
              </tr>
              <tr>
                <td style="width: 114px;" rowspan="1" colspan="1">
</td>
                <td style="width: 113px;" rowspan="1" colspan="1">
<p>Others</p>
</td>
                <td style="width: 138px;" rowspan="1" colspan="1">
</td>
                <td style="width: 664px;" rowspan="1" colspan="1">
<p>Cystic fibrosis, Budd-Chiari syndrome, hyperalimentation, graft versus host disease, trauma</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>MELD (model for end-stage liver disease) score&#x000a0;determines&#x000a0;the priority of the transplant. There are a few exceptions to the standard MELD score. Those are hepatic cellular carcinoma, hepatopulmonary syndrome,&#x000a0;Porto-pulmonary syndrome, familial amyloid polyneuropathy, cystic fibrosis, hilar cholangiocarcinoma, and acute liver failure withUnited Network for Organ Sharing status 1A/1B.<xref ref-type="bibr" rid="article-132869.r2">[2]</xref>&#x000a0;For hepatocellular carcinoma, the Milan criteria are used. It includes the liver tumor with a single&#x000a0;lesion less than 5 cm&#x000a0;or 2&#x000a0;to 3&#x000a0;lesions&#x000a0;of 1&#x000a0;to 3 cm.<xref ref-type="bibr" rid="article-132869.r3">[3]</xref></p>
      </sec>
      <sec id="article-132869.s4" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>The major contraindications for organ transplantation are active infection, active&#x000a0;malignancy, active drug abuse, reversible organ failure, uncontrollable psychiatry condition, non-compliance to treatment, and severe systemic condition with poor graft or patient survival. The recipient should wait for an organ transplant till infection or malignancy has been treated. For graft survival, it is essential to keep follow-up with the transplant team, regular clinic visits, blood work, and compliance with transplant medications. Hence, careful candidate selection becomes of utmost importance.<xref ref-type="bibr" rid="article-132869.r4">[4]</xref><xref ref-type="bibr" rid="article-132869.r5">[5]</xref></p>
      </sec>
      <sec id="article-132869.s5" sec-type="Equipment">
        <title>Equipment</title>
        <p>The standard American Society of Anesthesiology monitoring tools intra-operatively is 5 leads electrocardiogram, pulse oximeter, non-invasive blood pressure, and temperature. In addition to the standard tools, other invasive and non-invasive monitoring devices are used per the surgery. Major hemodynamic variation is anticipated in transplant surgeries, and invasive arterial blood pressure shows real-time values. Liver transplant patients are prone to severe hemodynamic fluctuation.</p>
        <p>Stroke volume variation and pulse pressure variation are dynamic metrics to&#x000a0;assist&#x000a0;the volume status of the patient. Depending on the institution's protocol, the patient can have one or two&#x000a0;arterial&#x000a0;lines (one&#x000a0;radial&#x000a0;and the other brachial or femoral). A central line is inserted&#x000a0;for central venous&#x000a0;pressure monitoring,&#x000a0;vasopressor, and inotropes administration. In some cases, when there is severe pulmonary hypertension, portopulmonary shunts, or diminished right heart function, a pulmonary artery (PA) catheter is inserted for pulmonary pressure monitoring. TEE (transesophageal echocardiogram) is used in some cases of liver transplantation for monitoring right and left heart function, diagnosing volume status of the patient, early diagnosis of cardiac clots, and guiding placement of PA catheter. TEE is contraindicated in grade III and IV esophageal varices.&#x000a0;&#x000a0;</p>
        <p>Intra-operative&#x000a0;arterial&#x000a0;blood gas analysis and thromboelastographic studies (TEG) are beneficial in liver transplant surgeries. The arterial gas analysis provides information on acid-base and electrolytes in the body. TEG studies help to understand the&#x000a0;coagulation&#x000a0;cascade and which hemostatic component deficiency is contributing to coagulopathy. Therefore, assisting in the repletion. Neuromuscular block monitoring is done with a train of four studies. It also guides with reversal and extubation of patients, especially in kidney and liver transplants where the metabolism of drugs is prolonged due to suppressed organ function. The bispectral index aids in decreasing awareness during anesthesia and&#x000a0;assists&#x000a0;in titrating drugs. Jugular&#x000a0;venous&#x000a0;oxygen saturation is used to&#x000a0;monitor&#x000a0;cerebral blood flow and oxygen consumption, especially in the&#x000a0;anhepatic&#x000a0;and&#x000a0;neohepatic&#x000a0;phases&#x000a0;of liver transplantation. There&#x000a0;is a significant fluctuation of cardiac output,&#x000a0;leading to impaired cerebral blood flow.<xref ref-type="bibr" rid="article-132869.r6">[6]</xref><xref ref-type="bibr" rid="article-132869.r7">[7]</xref><xref ref-type="bibr" rid="article-132869.r8">[8]</xref><xref ref-type="bibr" rid="article-132869.r9">[9]</xref></p>
      </sec>
      <sec id="article-132869.s6" sec-type="Preparation">
        <title>Preparation</title>
        <p>The preoperative evaluation and optimization should begin as soon as a person becomes a candidate for being an organ recipient. It plays a very crucial role in minimizing perioperative complications and improving graft and recipient survival.&#x000a0;The recipient is screened for malignancy, active infection, and other viral infections. The common screening includes human immunodeficiency virus, hepatitis panel, Epstein-Barr virus, and cytomegalovirus. They are tested accordingly depending on the comorbidities, such as coronary artery disease, peripheral artery disease, and cerebrovascular accidents. It is crucial to document allergies, prior&#x000a0;solid organ transplantation, prior blood transfusions, and&#x000a0;previous pregnancies. It assists in determining the antibody load in the recipient and guiding the immunosuppression regimen. Rabbit allergy is important to note as antithymocyte globulin is obtained from rabbit serum. Additional&#x000a0;testing is done as per&#x000a0;institutional&#x000a0;protocol.&#x000a0;Repeat evaluation every 2 years after the&#x000a0;initial&#x000a0;evaluation is&#x000a0;required&#x000a0;and sooner if the clinical situation changes.&#x000a0;&#x000a0;</p>
        <p>If the patient&#x000a0;has to&#x000a0;undergo coronary revascularization, then a multidisciplinary team&#x000a0;evaluation is&#x000a0;required. This team aids in&#x000a0;determining&#x000a0;the time and type of intervention&#x000a0;required. The duration of the dual antiplatelet regimen is a minimum of 4 weeks for balloon angioplasty, 3 months for a bare-metal stent, and 6 to 12 months for a drug-eluting stent.&#x000a0;There are no guidelines for pulmonary function testing. However, patients with uncontrolled chronic&#x000a0;obstructive&#x000a0;pulmonary disease, asthma, and interstitial lung disease should not undergo organ transplantation.&#x000a0;Pancreatic transplantation patients&#x000a0;are younger with fewer comorbidities. However, they may be at a greater risk of micro and macrovascular complications due to diabetes mellitus.<xref ref-type="bibr" rid="article-132869.r10">[10]</xref><xref ref-type="bibr" rid="article-132869.r11">[11]</xref><xref ref-type="bibr" rid="article-132869.r12">[12]</xref><xref ref-type="bibr" rid="article-132869.r13">[13]</xref><xref ref-type="bibr" rid="article-132869.r14">[14]</xref></p>
        <p>If the patient continues to be eligible for transplantation and an organ is&#x000a0;available,&#x000a0;surgery is planned.&#x000a0;It is crucial to thoroughly examine the airway before surgery and inquire about bleeding or clotting disorders, previous anesthesia exposure, type of anesthesia, any complications associated with previous exposure, and family history of anesthesia. Drug allergies are an important aspect of the preoperative evaluation to avoid any adverse reaction intra-operatively. An anesthesiologist should note consent for blood and blood product transfusion, history of previous blood transfusion, and adverse reaction. The device should be interrogated before surgery by the company representative in patients with a permanent pacemaker or defibrillator. Qualified personnel should be present in the operating room throughout the procedure to manage the device and revert its settings to baseline at the end. With all the above information and utmost diligence, anesthesia-related complications can be minimized intra-operatively.</p>
        <p>The following tests are done on the day of surgery:</p>
        <list list-type="bullet">
          <list-item>
            <p>Complete blood count with differentials&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Complete metabolic panel&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Coagulation&#x000a0;panel&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Blood group and&#x000a0;human leukocyte antigen crossmatch and typing&#x000a0;</p>
          </list-item>
          <list-item>
            <p>12 lead echocardiogram</p>
          </list-item>
          <list-item>
            <p>Chest x-ray</p>
          </list-item>
          <list-item>
            <p>Covid&#x000a0;nasopharyngeal antigen and antibody testing&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Thorough airway examination</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-132869.s7" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p><bold>General:</bold> Antibiotics and immunosuppression regimens based on transplant physician recommendations are administered during the day of surgery. The surgeon will perform back-table preparation of the donor organ.&#x000a0;&#x000a0;&#x000a0;</p>
        <p>
<bold>Kidney Transplant</bold>
</p>
        <p><bold>Dialysis&#x000a0;</bold> &#x000a0;</p>
        <p>The patient may or may not be&#x000a0;dialysis-dependent. An anesthesiologist should evaluate the patient's volume, electrolytes, and uremia status on the day of surgery. Initially, hemodialysis was avoided 24 hours before the transplant to decrease heparin in circulation. However, with the evolution of anesthesia care, point-of-care diagnostic tests, and techniques, it is no longer required.<xref ref-type="bibr" rid="article-132869.r15">[15]</xref><xref ref-type="bibr" rid="article-132869.r16">[16]</xref><xref ref-type="bibr" rid="article-132869.r17">[17]</xref></p>
        <p>
<bold>Intra-operative</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Maintain normothermia, position the patient, and secure the dialysis access site.&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Induction, muscle&#x000a0;relaxants&#x000a0;and inhalational agent:&#x000a0;&#x000a0;&#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <p><bold>Induction agents: </bold>The nephrotoxic drugs and opioids (morphine, meperidine, and codeine) are avoided. The opioids, as mentioned above, have active metabolites excreted by the kidney, which can accumulate.&#x000a0;Muscle relaxant and reversal agents: succinylcholine can cause an increase in serum potassium levels, which can be detrimental in ESRD patients. Cisatracurium&#x000a0;is metabolized by Hofmann elimination and can be used in renal failure patients. Laudanosine&#x000a0;is one of the breakdown products of atracurium and&#x000a0;cisatracurium. Kidneys&#x000a0;eliminate&#x000a0;it.&#x000a0;Cisatracurium&#x000a0;is more potent than atracurium. Hence, the amount of&#x000a0;laudanosine&#x000a0;generated is significantly less and below the toxic amount. The kidney partially excretes rocuronium. Sugammadex&#x000a0;is cleared from the kidney. However, it is found to have a complete reversal in kidney failure. Though clearance of the sugammadex&#x000a0;rocuronium complex takes time, no rebound muscle weakness is&#x000a0;observed.<xref ref-type="bibr" rid="article-132869.r18">[18]</xref><xref ref-type="bibr" rid="article-132869.r19">[19]</xref><xref ref-type="bibr" rid="article-132869.r20">[20]</xref></p>
        <p><bold>Inhalational agents: </bold>Oxygen and air or oxygen and nitrous oxide combination are routinely used with the inhalational agent. Sevoflurane administration can lead to the accumulation of inorganic fluoride ions and compound A in patients with renal&#x000a0;insufficiency. However, the FDA (Food and Drug Administration) has approved&#x000a0;safe sevoflurane administration with&#x000a0;fresh gas flows greater than 1 liter/minute. Isoflurane and desflurane can be used as an alternative to sevoflurane.&#x000a0;</p>
        <p><bold>Fluid Status</bold>&#x000a0;</p>
        <p>Depending on the volume status of the patient preoperatively, volume replacement&#x000a0;is performed. Using the acetated or lactated solution can lead to an increase in potassium levels in patients with end-stage renal disease (ESRD). Normal saline causes hyperchloremic acidosis, taking longer to normalize the acid-base status. Adequate graft perfusion is vital to avoid delayed graft function or ischemia-perfusion injury. The auto-regulatory mechanism is not present in the transplanted kidney. Colloids are not the preferred choice for volume replacement.&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</p>
        <p>Depending on the volume status of the patient preoperatively, replace volume. There were concerns&#x000a0;regarding&#x000a0;using acetated or lactated solution, causing an increase in potassium levels in patients with ESRD. Normal saline causes hyperchloremic acidosis, taking longer to clear acid. Adequate graft perfusion is vital&#x000a0;to&#x000a0;avoid delayed graft function or ischemia-perfusion injury. The auto-regulatory mechanism is not present in the transplanted kidney. Colloids are not the preferred choice for volume replacement. Dynamic blood pressure monitoring with stroke volume variation and pulse pressure variation&#x000a0;assists&#x000a0;in&#x000a0;maintaining&#x000a0;adequate volume&#x000a0;resuscitation. Vasopressors like norepinephrine with alpha and beta-blocker activity have shown decreased elevation in the renal resistive indices. Previously, low-dose dopamine was preferred. However, it has been shown to be harmful to renal grafts and is no longer used.<xref ref-type="bibr" rid="article-132869.r21">[21]</xref></p>
        <p>
<bold>Immunosuppression</bold>
</p>
        <p>Mycophenolate and&#x000a0;methyl-prednisolone&#x000a0;are given before surgery. Thymoglobulin is given intra-operatively. The rate is adjusted based on the blood pressure of the patient. If the&#x000a0;initial&#x000a0;dose causes hypotension, the rate is reduced to half.&#x000a0;&#x000a0;&#x000a0;&#x000a0;</p>
        <p>
<bold>Pancreatic Transplant</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>A thorough airway examination becomes vital in a diabetic patient as there is an increased incidence of stiffness&#x000a0;of the atlantoaxial joint.&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pancreatic transplant surgery is done under general anesthesia with an inducing agent, muscle relaxant, and opioids. If there are concerns for cardiovascular instability, etomidate is preferred for induction. Diabetic patients can have gastroparesis; if it is present, rapid sequence induction is done. After pancreas transplantation, the pancreas starts functioning within 5 minutes. Strict glucose monitoring is&#x000a0;required&#x000a0;to avoid pancreatic cell dysfunction. Frequent glucose level tests every 15 minutes for an hour, followed by every 30 minutes. No major fluid shift is&#x000a0;anticipated&#x000a0;in pancreatic transplant surgery. The blood pressure goal is to&#x000a0;maintain the baseline a little high after the transplant to&#x000a0;maintain&#x000a0;adequate blood flow to the graft.<xref ref-type="bibr" rid="article-132869.r22">[22]</xref><xref ref-type="bibr" rid="article-132869.r23">[23]</xref></p>
          </list-item>
        </list>
        <p><bold>Liver Transplant</bold>&#x000a0;&#x000a0;</p>
        <p><bold>Induction, muscle relaxant and inhalational agents </bold>&#x000a0;</p>
        <p><bold>Induction:</bold> Rapid sequence induction is preferred if there is a concern for aspiration, especially if the recipient is not fasting or has gastroparesis or ascites. Pharmacodynamics and pharmacokinetics of drugs are altered&#x000a0;in liver&#x000a0;transplant recipients due to decreased serum&#x000a0;albumin, increase&#x000a0;in the volume of distribution of drugs, and changes in the metabolization of drugs via the liver. The inducing agents should be carefully administered as they&#x000a0;impact&#x000a0;systemic blood pressure and hepatic blood flow. Etomidate has been shown to decrease hepatic blood flow with unpredictable clinical recovery. Propofol is a vasodilator with a moderate decrease in hepatic blood flow.&#x000a0;&#x000a0;</p>
        <p><bold>Muscle relaxants:</bold> Atracurium and&#x000a0;cisatracurium&#x000a0;are used as they are metabolized via Hofmann degradation. Rocuronium can be used if&#x000a0;sugammadex&#x000a0;is available.&#x000a0;&#x000a0;</p>
        <p><bold>Inhalational agents:</bold> Desflurane and sevoflurane do not affect hepatic blood flow.&#x000a0;&#x000a0;</p>
        <p><bold>Vasopressors and inotropes:</bold> They should be kept available as hemodynamic fluctuations are&#x000a0;anticipated. Common reasons are coagulopathy, extensive blood, decrease in preload, third space loss, and reperfusion syndrome. Epinephrine, norepinephrine, and dopamine are used first. Vasopressin is used in&#x000a0;refractory&#x000a0;hypotension.&#x000a0;&#x000a0;&#x000a0;</p>
        <p><bold>Intravenous volume&#x000a0;resuscitation:</bold> Albumin synthesis is affected in end-stage liver disease. Albumin has shown decreased mortality, crystalloid requirements, the need for vasoactive drugs, the incidence of pulmonary edema, and post-reperfusion syndrome. With hydroxyethyl starch, there is an increase in coagulopathy, decreased platelet&#x000a0;aggregation, and factor VIII levels. Isotonic K crystalloid is preferred. Normal saline used in large volumes can cause a rapid rise in sodium levels, which increases the incidence of central pontine myelinolysis. Lactated ringers in liver failure can lead to the accumulation of lactate, leading to lactic acidosis. Cell savers are used for autologous blood transfusion; however, their use is contraindicated in infection and neoplasia.<xref ref-type="bibr" rid="article-132869.r24">[24]</xref><xref ref-type="bibr" rid="article-132869.r25">[25]</xref></p>
        <p>
<bold>Different Phases&#x000a0;in Liver Transplantation </bold>
</p>
        <p>Each phase is associated with its own set of pathophysiological changes. It is essential to recognize it and&#x000a0;anticipate&#x000a0;complications with a plan in place.&#x000a0;&#x000a0;&#x000a0;</p>
        <p>
<bold>Pre hepatic phase&#x000a0;&#x000a0;</bold>
</p>
        <p>It begins from the&#x000a0;incision&#x000a0;of the skin till the clamping of the inferior vena&#x000a0;cava. Hypotension is expected in this phase. It can be due to sudden loss of ascitic fluid, portal hypertension,&#x000a0;portopulmonary&#x000a0;shunts, and bleeding from the surgical site, worsened by coagulopathy associated with end-stage liver disease. Mindful administration of fluids (choice of fluid as above) is essential. Thromboelastography studies are beneficial. Excessive volume&#x000a0;resuscitation&#x000a0;should also be avoided as it can lead to dilutional coagulopathy and thrombocytopenia. Octreotide infusion can be used in portal hypertension and requires careful monitoring. It reduces the need for blood transfusion and improves renal function. If, despite all these efforts, hypotension persists, consider&#x000a0;veno-venous bypass.<xref ref-type="bibr" rid="article-132869.r26">[26]</xref><xref ref-type="bibr" rid="article-132869.r27">[27]</xref></p>
        <p>
<bold>Anhepatic phase&#x000a0;</bold>
</p>
        <p>It begins with&#x000a0;the&#x000a0;clamping of hepatic vein flow till&#x000a0;vascular anastomosis&#x000a0;is&#x000a0;achieved. Hypotension is a common complication in this phase&#x000a0;due to a decrease in preload, causing decreased cardiac output. In&#x000a0;refractory&#x000a0;hypotension, portosystemic&#x000a0;shunt&#x000a0;or&#x000a0;veno-venous&#x000a0;shunt&#x000a0;should be considered. It is essential to ensure that cerebral blood flow is not compromised in this stage. Lactate, citrate, and other metabolites accumulate in the body, causing acidosis, hypocalcemia, and hyperkalemia. For hyperkalemia, insulin with dextrose, bicarbonate, loop diuretics, and tromethamine is administered. Renal replacement therapy should be considered as a last resort. Coagulopathy is&#x000a0;not uncommon&#x000a0;during this stage; TEG studies will&#x000a0;assist&#x000a0;in correction. Consider correction only if clinically&#x000a0;indicated, as correction does occur in the&#x000a0;neo-hepatic&#x000a0;stage. In hepatitis B-positive recipients, hepatitis B hyperimmunoglobulin is administered in this stage. Monitor&#x000a0;for allergic&#x000a0;reactions to hepatitis B hyperimmunoglobulin.<xref ref-type="bibr" rid="article-132869.r28">[28]</xref><xref ref-type="bibr" rid="article-132869.r29">[29]</xref></p>
        <p>
<bold>Neohepatic phase</bold>
</p>
        <p>It begins with reperfusion of the liver until blood flow resumes to the portal vein and inferior vena cava. It is preferred to keep mean&#x000a0;arterial&#x000a0;pressure between 80 and 100 mm&#x000a0;Hg before revascularization is&#x000a0;established. Post-reperfusion syndrome, worsening pulmonary hypertension, right heart failure, and malignant arrhythmia need to be&#x000a0;monitored&#x000a0;in&#x000a0;this stage. Volume&#x000a0;resuscitation, autologous blood transfusion (preferred overpacked red blood cells due to low potassium content), and inotropes are administered as clinically&#x000a0;indicated. After re-establishing blood flow, a sudden release of metabolites and vasodilatory substances can occur, leading to a sudden fall in blood pressure and malignant arrhythmias. In case of hyperkalemia causing echocardiogram changes, intravenous calcium chloride helps to stabilize the cardiac membrane. In the event of&#x000a0;a cardiac arrest, an&#x000a0;incision&#x000a0;should be made in the diaphragm, and an internal cardiac massage should be delivered. TTE can&#x000a0;assist&#x000a0;in diagnosing volume status, cardiac clots, and cardiac function and treat accordingly. If cardiac clots are detected, and there are concerns for pulmonary thromboembolism, heparin, and tissue plasminogen activator are administered.<xref ref-type="bibr" rid="article-132869.r30">[30]</xref><xref ref-type="bibr" rid="article-132869.r31">[31]</xref></p>
      </sec>
      <sec id="article-132869.s8" sec-type="Complications">
        <title>Complications</title>
        <p>During organ transplant surgeries, complications are related to anesthetic agents, immunosuppression,&#x000a0;organ dysfunction, acid-base and electrolyte imbalances, coagulopathy, and blood loss. These are further elaborated individually in different types of transplant surgeries.</p>
      </sec>
      <sec id="article-132869.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Solid organ transplantations involving the kidney, pancreas, and liver pose a unique challenge perioperatively. Thorough preoperative evaluation and preparedness for&#x000a0;anticipated&#x000a0;complications during the surgery can improve surgical outcomes associated with these complex procedures.</p>
      </sec>
      <sec id="article-132869.s10" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interdisciplinary team is&#x000a0;required&#x000a0;for a successful transplant. The team includes the United Network for Organ Sharing and local organ procurement organization, transportation team of an organ from donor to recipient, transplant anesthesiologists, transplant surgeons, operating room members, transplant pharmacists, transplant physicians, radiologist, physical therapist, occupational therapist, nutritionist, social worker,&#x000a0;and strong social support.<xref ref-type="bibr" rid="article-132869.r32">[32]</xref></p>
        <p>Successful transplant surgery and survival of graft involve tremendous coordination between the team members due to the complexity of care involved, extending beyond the perioperative period.&#x000a0;If the patient&#x000a0;has to&#x000a0;undergo coronary revascularization, then evaluation by a cardiology consultant is required. The consultant will determine&#x000a0;the time and type of intervention&#x000a0;required.&#x000a0;<xref ref-type="bibr" rid="article-132869.r12">[12]</xref>&#x000a0;There are no guidelines for pulmonary function testing. However, patients with uncontrolled chronic&#x000a0;obstructive&#x000a0;pulmonary disease, asthma, and interstitial lung disease should be evaluated by a pulmonologist before being considered for organ donation. Hemodialysis can be performed 24 hours before kidney transplant and does not impact early graft function. Therefore, coordination with the nephrologist for evaluation for dialysis is recommended.<xref ref-type="bibr" rid="article-132869.r15">[15]</xref></p>
      </sec>
      <sec id="article-132869.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=132869&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=132869">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/132869/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=132869">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-132869.s12">
        <title>References</title>
        <ref id="article-132869.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suthanthiran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Strom</surname>
                <given-names>TB</given-names>
              </name>
            </person-group>
            <article-title>Renal transplantation.</article-title>
            <source>N Engl J Med</source>
            <year>1994</year>
            <month>Aug</month>
            <day>11</day>
            <volume>331</volume>
            <issue>6</issue>
            <fpage>365</fpage>
            <page-range>365-76</page-range>
            <pub-id pub-id-type="pmid">7832839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Massie</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Caffo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gentry</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Axelrod</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Lentine</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Schnitzler</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gheorghian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salvalaggio</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Segev</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>MELD Exceptions and Rates of Waiting List Outcomes.</article-title>
            <source>Am J Transplant</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>11</volume>
            <issue>11</issue>
            <fpage>2362</fpage>
            <page-range>2362-71</page-range>
            <pub-id pub-id-type="pmid">21920019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Milan criteria and its expansions in liver transplantation for hepatocellular carcinoma.</article-title>
            <source>Hepatobiliary Surg Nutr</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>5</volume>
            <issue>6</issue>
            <fpage>498</fpage>
            <page-range>498-502</page-range>
            <pub-id pub-id-type="pmid">28124007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bachir</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Adult liver transplantation in the United States.</article-title>
            <source>Am J Med Sci</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>343</volume>
            <issue>6</issue>
            <fpage>462</fpage>
            <page-range>462-9</page-range>
            <pub-id pub-id-type="pmid">22683615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rice</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Lucey</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Should length of sobriety be a major determinant in liver transplant selection?</article-title>
            <source>Curr Opin Organ Transplant</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>259</fpage>
            <page-range>259-64</page-range>
            <pub-id pub-id-type="pmid">23492643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nasa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tandon</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Perioperative monitoring in liver transplant patients.</article-title>
            <source>J Clin Exp Hepatol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>271</fpage>
            <page-range>271-8</page-range>
            <pub-id pub-id-type="pmid">25755443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schumann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mandell</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Mercaldo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Michaels</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Klinck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pandharipande</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Walia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Anesthesia for liver transplantation in United States academic centers: intraoperative practice.</article-title>
            <source>J Clin Anesth</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>7</issue>
            <fpage>542</fpage>
            <page-range>542-50</page-range>
            <pub-id pub-id-type="pmid">23994704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendizabal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>MO</given-names>
              </name>
            </person-group>
            <article-title>Liver transplantation in acute liver failure: A challenging scenario.</article-title>
            <source>World J Gastroenterol</source>
            <year>2016</year>
            <month>Jan</month>
            <day>28</day>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>1523</fpage>
            <page-range>1523-31</page-range>
            <pub-id pub-id-type="pmid">26819519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cao</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Chi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>YX</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>XC</given-names>
              </name>
            </person-group>
            <article-title>Effect of bispectral index-guided anesthesia on consumption of anesthetics and early postoperative cognitive dysfunction after liver transplantation: An observational study.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>96</volume>
            <issue>35</issue>
            <fpage>e7966</fpage>
            <pub-id pub-id-type="pmid">28858130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lentine</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Weir</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Robb</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Fleisher</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Kasiske</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Carithers</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Ragosta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bolton</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Auerbach</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>KA</given-names>
              </name>
              <collab>American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Peripheral Vascular Disease</collab>
              <collab>American Heart Association</collab>
              <collab>American College of Cardiology Foundation</collab>
            </person-group>
            <article-title>Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation: endorsed by the American Society of Transplant Surgeons, American Society of Transplantation, and National Kidney Foundation.</article-title>
            <source>Circulation</source>
            <year>2012</year>
            <month>Jul</month>
            <day>31</day>
            <volume>126</volume>
            <issue>5</issue>
            <fpage>617</fpage>
            <page-range>617-63</page-range>
            <pub-id pub-id-type="pmid">22753303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pilmore</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dent</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Chadban</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Reduction in cardiovascular death after kidney transplantation.</article-title>
            <source>Transplantation</source>
            <year>2010</year>
            <month>Apr</month>
            <day>15</day>
            <volume>89</volume>
            <issue>7</issue>
            <fpage>851</fpage>
            <page-range>851-7</page-range>
            <pub-id pub-id-type="pmid">20048695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fleisher</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fleischmann</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Auerbach</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Barnason</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Beckman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Davila-Roman</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Gerhard-Herman</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Holly</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Marine</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ting</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Uretsky</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Wijeysundera</surname>
                <given-names>DN</given-names>
              </name>
              <collab>American College of Cardiology</collab>
              <collab>American Heart Association</collab>
            </person-group>
            <article-title>2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2014</year>
            <month>Dec</month>
            <day>09</day>
            <volume>64</volume>
            <issue>22</issue>
            <fpage>e77</fpage>
            <page-range>e77-137</page-range>
            <pub-id pub-id-type="pmid">25091544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berney</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Malaise</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Toso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Demuylder-Mischler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Majno</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>B&#x000fc;hler</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Mentha</surname>
                <given-names>G</given-names>
              </name>
              <collab>Euro-SPK Study Group</collab>
            </person-group>
            <article-title>Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2005</year>
            <month>May</month>
            <volume>20 Suppl 2</volume>
            <fpage>ii48</fpage>
            <page-range>ii48-53, ii62</page-range>
            <pub-id pub-id-type="pmid">15814550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dieterle</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Schmauss</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arbogast</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Domsch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Landgraf</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary function in patients with type 1 diabetes before and after simultaneous pancreas and kidney transplantation.</article-title>
            <source>Transplantation</source>
            <year>2007</year>
            <month>Mar</month>
            <day>15</day>
            <volume>83</volume>
            <issue>5</issue>
            <fpage>566</fpage>
            <page-range>566-9</page-range>
            <pub-id pub-id-type="pmid">17353775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kiki&#x00107;</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lorenz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sunder-Plassmann</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schillinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Regele</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gy&#x000f6;ri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>M&#x000fc;hlbacher</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Winkelmayer</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hmig</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Effect of hemodialysis before transplant surgery on renal allograft function--a pair of randomized controlled trials.</article-title>
            <source>Transplantation</source>
            <year>2009</year>
            <month>Dec</month>
            <day>27</day>
            <volume>88</volume>
            <issue>12</issue>
            <fpage>1377</fpage>
            <page-range>1377-85</page-range>
            <pub-id pub-id-type="pmid">20029334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jalal</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Chonchol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Targher</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Disorders of hemostasis associated with chronic kidney disease.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-40</page-range>
            <pub-id pub-id-type="pmid">20391294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pivalizza</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Abramson</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Perioperative hypercoagulability in uremic patients: a viscoelastic study.</article-title>
            <source>J Clin Anesth</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>442</fpage>
            <page-range>442-5</page-range>
            <pub-id pub-id-type="pmid">9278828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Plane</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Marsan</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>du Cheyron</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Valette</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Rapidly changing ECG in hyperkalaemia after succinylcholine.</article-title>
            <source>Lancet</source>
            <year>2019</year>
            <month>May</month>
            <day>11</day>
            <volume>393</volume>
            <issue>10184</issue>
            <fpage>1983</fpage>
            <pub-id pub-id-type="pmid">31084970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cammu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Van Vlem</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>van den Heuvel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>el Galta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Eloot</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Demeyer</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment.</article-title>
            <source>Br J Anaesth</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>109</volume>
            <issue>3</issue>
            <fpage>382</fpage>
            <page-range>382-90</page-range>
            <pub-id pub-id-type="pmid">22732111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Staals</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Snoeck</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Driessen</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Flockton</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Heeringa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function.</article-title>
            <source>Br J Anaesth</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>101</volume>
            <issue>4</issue>
            <fpage>492</fpage>
            <page-range>492-7</page-range>
            <pub-id pub-id-type="pmid">18653492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hadimioglu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Saadawy</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Saglam</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ertug</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Dinckan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation.</article-title>
            <source>Anesth Analg</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>107</volume>
            <issue>1</issue>
            <fpage>264</fpage>
            <page-range>264-9</page-range>
            <pub-id pub-id-type="pmid">18635497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larson-Wadd</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Belani</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Pancreas and islet cell transplantation.</article-title>
            <source>Anesthesiol Clin North Am</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>4</issue>
            <fpage>663</fpage>
            <page-range>663-74</page-range>
            <pub-id pub-id-type="pmid">15541929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koehntop</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Beebe</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Belani</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Perioperative anesthetic management of the kidney-pancreas transplant recipient.</article-title>
            <source>Curr Opin Anaesthesiol</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>341</fpage>
            <page-range>341-7</page-range>
            <pub-id pub-id-type="pmid">17016326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haynes</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Navickis</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Wilkes</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Albumin administration--what is the evidence of clinical benefit? A systematic review of randomized controlled trials.</article-title>
            <source>Eur J Anaesthesiol</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>10</issue>
            <fpage>771</fpage>
            <page-range>771-93</page-range>
            <pub-id pub-id-type="pmid">14580047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hand</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Whiteley</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Epperson</surname>
                <given-names>TI</given-names>
              </name>
              <name>
                <surname>Tam</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Crego</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chavin</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Taber</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: a single-center retrospective review.</article-title>
            <source>Anesth Analg</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>120</volume>
            <issue>3</issue>
            <fpage>619</fpage>
            <page-range>619-626</page-range>
            <pub-id pub-id-type="pmid">25036375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mallett</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>Clinical Utility of Viscoelastic Tests of Coagulation (TEG/ROTEM) in Patients with Liver Disease and during Liver Transplantation.</article-title>
            <source>Semin Thromb Hemost</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>41</volume>
            <issue>5</issue>
            <fpage>527</fpage>
            <page-range>527-37</page-range>
            <pub-id pub-id-type="pmid">26049072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fonouni</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mehrabi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Soleimani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>B&#x000fc;chler</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The need for venovenous bypass in liver transplantation.</article-title>
            <source>HPB (Oxford)</source>
            <year>2008</year>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>196</fpage>
            <page-range>196-203</page-range>
            <pub-id pub-id-type="pmid">18773054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adelmann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kronish</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ramsay</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Anesthesia for Liver Transplantation.</article-title>
            <source>Anesthesiol Clin</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>491</fpage>
            <page-range>491-508</page-range>
            <pub-id pub-id-type="pmid">28784222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Senzolo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cholongitas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Thalheimer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Riddell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mallett</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ferronato</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Burroughs</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Heparin-like effect in liver disease and liver transplantation.</article-title>
            <source>Clin Liver Dis</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-53</page-range>
            <pub-id pub-id-type="pmid">19150308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boone</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Sherwani</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Herborn</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>De Wolf</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac/pulmonary thrombosis during liver transplantation.</article-title>
            <source>Anesth Analg</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>112</volume>
            <issue>2</issue>
            <fpage>319</fpage>
            <page-range>319-21</page-range>
            <pub-id pub-id-type="pmid">21127275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bukowicka</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Akar</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Olszewska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Smoter</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Krawczyk</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival.</article-title>
            <source>Ann Transplant</source>
            <year>2011</year>
            <season>Apr-Jun</season>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>26</fpage>
            <page-range>26-30</page-range>
            <pub-id pub-id-type="pmid">21716182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-132869.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boulware</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Hill-Briggs</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kraus</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Melancon</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Falcone</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ephraim</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Jaar</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Gimenez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Senga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kolotos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lewis-Boyer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Light</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>DePasquale</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Noletto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Powe</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trial.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>476</fpage>
            <page-range>476-86</page-range>
            <pub-id pub-id-type="pmid">23089512</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
